New indications for old antibiotics: tetracycline, erythromycin, carbenicillin, and vancomycin revisited.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002228:Carbenicillin / Q000627:therapeutic use; D002981:Clindamycin / Q000009:adverse effects; D003967:Diarrhea / Q000188:drug therapy; D004761:Enterocolitis, Pseudomembranous / Q000139:chemically induced / Q000188:drug therapy; D004917:Erythromycin / Q000627:therapeutic use; D006801:Humans; D007877:Legionnaires' Disease / Q000188:drug therapy; D008171:Lung Diseases / Q000188:drug therapy; D008297:Male; D008712:Methicillin / Q000494:pharmacology; D010403:Penicillin Resistance; D011472:Prostatitis / Q000188:drug therapy; D013203:Staphylococcal Infections / Q000188:drug therapy; D013211:Staphylococcus aureus / Q000187:drug effects; D013296:Streptococcus pneumoniae / Q000187:drug effects; D013752:Tetracycline / Q000627:therapeutic use; D014526:Urethritis / Q000188:drug therapy; D014640:Vancomycin / Q000494:pharmacology / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D002981:Clindamycin; D004917:Erythromycin; D014640:Vancomycin; D013752:Tetracycline; D002228:Carbenicillin; D008712:Methicillin